Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease #ESMO24
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers (2) who gain clinically meaningful benefit from adding immunotherapy to current standard treatments,…
TUMORE: DALLA PRATICA CLINICA ALL’ INNOVAZIONE IN DIAGNOSI E CURA. CONGRESSO #ESMO24
Il Congresso ESMO 2024 in corso a Barcellona offre una panoramica completa dell’attuale panorama dello sviluppo dei farmaci, con i medicinali esistenti che dimostrano benefici in applicazioni aggiuntive e nuovi…